NLRP3 and Alzheimer disease: Notably, gut microbial metabolites such as SCFAs, whose levels decline with age-related dysbiosis, normally suppress NLRP3 activation [54], highlighting a direct link between GM dysregulation and inflammasome-mediated neuroinflammatory processes in AD.